Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Baricitinib may effectively treat oral lichen planus.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Switching from infliximab to Ustekinumab improved both hair loss and Crohn's symptoms in the patient.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Leflunomide and anthralin may effectively treat severe alopecia areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Both treatments for localized alopecia areata are equally effective.

Topical IKKα inhibitors may help prevent CCS tumours.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.